VITAL, a BARDA Accelerator Network (BAN) Hub, supports the development and acceleration of next-generation therapeutic and vaccine platforms and technologies. It is led by Start2 Group in partnership with Advise Connect Inspire (ACI) and BioLabs. VITAL provides a global innovation network to enable impactful collaborations between the U.S. and other health security communities and their innovation ecosystems around the world.